Cargando…
Gamma secretase inhibitors of Notch signaling
The numerous processes involved in the etiology of breast cancer such as cell survival, metabolism, proliferation, differentiation, and angiogenesis are currently being elucidated. However, underlying mechanisms that drive breast cancer progression and drug resistance are still poorly understood. As...
Autores principales: | Olsauskas-Kuprys, Roma, Zlobin, Andrei, Osipo, Clodia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726525/ https://www.ncbi.nlm.nih.gov/pubmed/23901284 http://dx.doi.org/10.2147/OTT.S33766 |
Ejemplares similares
-
Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
por: Clementz, Anthony G, et al.
Publicado: (2009) -
Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
por: Baker, Andrew T., et al.
Publicado: (2014) -
Trastuzumab Resistance: Role for Notch Signaling
por: Mehta, Kinnari, et al.
Publicado: (2009) -
Notch Signaling in Breast Cancer: A Role in Drug Resistance
por: BeLow, McKenna, et al.
Publicado: (2020) -
Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma
por: Abedin, Yasmin, et al.
Publicado: (2022)